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at the synapse. Regardless of the final explanation for readily grow in vivo into an implanted graft of PNS tissue
the unexpected results with LAT, genetics has served (Richardson et al., 1980; David and Aguayo, 1981).
its purpose in calling attention to a molecule that is not An environment favorable to regeneration, however,
a usual suspect at the synapse. is not all that is needed. Further work showed that a
How, in the end, should we think about the learning primary lesion in the peripheral branch of the dorsal root
phenotype of latheo mutants? Is it a result of defective ganglion (DRG), followed by a second lesion in the spinal
mushroom body development, impaired synaptic plas- branch of the same nerve at the same time or weeks
ticity, or both? A satisfying answer must await the identi- later, results in more extensive growth into peripheral
fication of mutants that separate the roles of lat at the nerve grafts situated in the dorsal columns. The condi-
chromosome and the synapse, or the creation of condi- tioning peripheral nerve lesion somehow encourages
tional mutants that rescue only the developmental de- growth for the majority of lesioned spinal axons to the
fects. In the meantime, these two papers in Neuron may most distal edge of the graft but still not into the host
inspire neurobiologists to head to the library for a re- CNS tissue beyond. In spite of the conditioning lesion
fresher course on DNA replication. effect, it appears that a glial scar at the graft±host bor-
der, along with myelin-specific inhibitors, ultimately
halts axonal growth (Richardson and Issa, 1984; Oudega
Aaron DiAntonio et al., 1994). What is notable about these animal experi-
Department of Molecular and Cell Biology ments is that the CNS axons grow better if their periph-
University of California, Berkeley eral branch has been previously cut. Even a conditioning
Berkeley, California 94720 lesion in the peripheral branch of a DRG, followed by a
second peripheral branch lesion of the same nerve
rather than a central lesion, leads to more rapid regener-Selected Reading
ation (McQuarrie and Grafstein, 1973). Together, these
experiments suggest a strong environmental influenceBoynton, S., and Tully, T. (1992). Genetics 131, 655±672.
on regeneration, but they also point to some intrinsicDubnau, J., and Tully, T. (1998). Annu. Rev. Neurosci. 21, 407±444.
properties of the neuron that must affect the extentGatti, M., and Baker, B.S. (1989). Genes Dev. 3, 438±453.
of regeneration. A conditioning lesion in the peripheralGossen, M., Pak, D.T.S., Hansen, S.K., Acharya, J.K., and Botchan,
M.R. (1995). Science 270, 1674±1677. branch of the sciatic nerve induces an intrinsic change
in the neuron that allows either the peripheral or centralHeisenberg, M., Borst, A., Wagner, S., and Byers, D. (1985). J. Neuro-
genet. 2, 1±30. branch to subsequently grow better after injury.
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Nusslein-Volhard, C., and Weischaus, E. (1980). Nature 287, strating that transected dorsal column axons regenerate
795±801. when a conditioning lesion is first created in the periph-
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ton, S., Jones, C.J., Hendricks, M., Velinzon, K., Wohlschlegel, J.A.,
important, and different, is not the substantial distanceet al. (1999). Neuron 23, this issue, 45±54.
traversed by the regenerating dorsal column axons, norRohrbough, J., Pinto, S., Mihalek, R.M., Tully, T., and Broadie, K.
the possibly greater number of regenerating axons com-(1999). Neuron 23, this issue, 55±70.
pared to other studies, but rather that no peripheralRowles, A., and Blow, J.J. (1997). Curr. Opin. Genet. Dev. 7, 152±157.
nerve graft was used. Regeneration occurred into whatZhong, Y., and Wu, C.F. (1991). Science 251, 198±201.
is, by all previous criteria, the highly nonpermissive envi-
ronment of the damaged spinal cord (see figure). After
corticospinal tract lesions by Schwab and colleagues,
regeneration also occurred over relatively long dis-
tances, but these studies employed the monoclonal an-The Benefits of Adding tibody IN-1, which neutralizes some of the myelin-spe-
Insult to Injury cific inhibitors of regeneration (Bregman et al., 1995). In
the study reported here, regeneration occurred without
blocking myelin or glial scar inhibitors. Transecting the
dorsal column and simultaneously lesioning the periph-A persistent, central question in neurobiology is, why
eral nerve results in extensive regeneration into the le-do the axons of the PNS regenerate after injury while
sion site but not beyond. Significantly, however, Neu-CNS axons do not? Several factors are known to prevent
mann and Woolf (1999) show that when the conditioningCNS regeneration: glial scarring (which presents both a
lesion in the peripheral nerve is performed 1 week beforephysical barrier and inhibitors to regeneration), myelin-
the dorsal column transection, about 50% of the animalsspecific inhibitors, and possibly the loss of general
show axon regrowth around the site of injury and intogrowth capacity by adult CNS axons. In contrast, the
the gray matter surrounding the central canal, with littlePNS regenerates largely because of the environmental
or no growth into the lesion site itself. Furthermore,changes following injury. Myelin debris is cleared and
these axons continue to grow both caudally and rostrallySchwann cells dedifferentiate, downregulating expres-
from the lesion site. In the remaining half of the prele-sion of myelin proteins and thus becoming permissive
sioned animals, axons did grow into the lesion site, con-for regeneration. Not surprisingly, a number of studies,
going back over a decade, demonstrate that CNS axons tinuing on through the lesion and beyond, to grow mostly
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Sites of Preconditioning Peripheral Branch
Lesion and Subsequent Central Branch Le-
sion in Dorsal Root Ganglion Nerves
Preconditioning lesions were created in the
sciatic nerve (L4±L6) (1) either simultaneously
with, or 1 or 2 weeks prior to, a dorsal column
transection at T6±T7 (2). Regeneration oc-
curred through the dorsal column lesion site
if the preconditioning lesion preceded the
dorsal column lesion by 1 or 2 weeks; re-
growth occurred only into the lesion if the
preconditioning lesion was inflicted at the
same time; no regeneration occurred without
a peripheral lesion. The dashed line shows
the sites of lesions.
through host gray matter but with considerable regener- growth cones by a soluble form of MAG, and by a num-
ber of other inhibitory molecules, can be switched toation also observed in white matter. A 2-week condition-
ing lesion resulted in slightly less effective dorsal column attraction by elevating cAMP (Song et al., 1998). To-
gether, these important results suggest that the neu-regeneration than a 1-week conditioning lesion. Without
the peripheral nerve conditioning lesion, dorsal column ronal response to myelin inhibitors (and, although never
tested, possibly also to inhibitors in the glial scar) isaxons did not regenerate. Finally, in culture, neurite
growth from DRG explants was longer following an in dictated by the neuron's endogenous levels of cAMP.
Therefore, it is quite likely that transection of the periph-vivo conditioning lesion than without one.
So, what is responsible for this regrowth? How can a eral nerve branch of DRG neurons results in an increase
in endogenous levels of cAMP, perhaps reaching levelslesion in the peripheral nervous system affect the regen-
eration capabilities of the CNS branch of the same found in young animals. This may neutralize the effect
of myelin inhibitors or effectively switch the responsenerve? The study by Neumann and Woolf (1999), along
with previous studies, suggests that the growth capacity of axons to myelin inhibitors to promotion, thereby
allowing them to grow through white matter. Therefore,of the dorsal column axons is clearly improved by a
preconditioning lesion. We do not know, however, the the combined effect of a conditioning lesion on both
increased growth capacity and the ability to growmolecular mechanism underlying this improved growth
capacity, nor do we know why these axons are not through inhibitors could account for the pattern of re-
growth of these dorsal spinal axons in the damagedstopped by inhibitory molecules within the glial scar and
myelin. One possibility is that growth commences before spinal cord.
If cAMP does play a major role in this improved growththe glial scar can form. Alternatively, the glial scar might
form differently after a conditioning lesion. Since inhibi- through damaged spinal tissue, the next obvious ques-
tions are (1) what is activated or inactivated to achievetors in myelin, whether soluble or membrane associated,
are exposed/secreted in response to damage regard- this effect and (2) is the response dependent on protein
synthesis? Because growth is better after a 1 week con-less of whether there is a lesion to the peripheral nerve,
regrowing central axons will confront them in both ditioning lesion than when the two lesions are created
at the same time, time-dependent changes must occurcases. However, a peripheral nerve lesion might alter the
response of regrowing dorsal column axons to myelin in the damaged spinal column axon to allow it to regrow.
Consistent with this prediction, Smith and Skene (1997)inhibitors and inhibitors in general. For example, periph-
eral lesions may lead to the downregulation of the recep- show that after axotomy, adult DRG axons grow differ-
ently, becoming more elongated rather than branched,tors for these inhibitors on the central regenerating
growth cone. Alternatively, inhibitor receptors may still and that this transition requires ongoing transcription
for a limited period after injury. An obvious candidatebe expressed after a peripheral lesion, but they may no
longer signal inhibition. Three recent observations make molecule to give improved growth is the growth-associ-
ated protein GAP43, which is upregulated in spinal ax-this latter interpretation compelling. First, like many im-
mature neurons, growth of embryonic and neonatal DRG ons after a conditioning lesion. However, preliminary
results suggest that there is no improved regeneration inneurons is not inhibited by myelin (Shewan et al., 1995).
For one myelin-specific inhibitor, myelin-associated gly- transgenic mice overexpressing GAP43 (Neumann and
Woolf, 1999).coprotein (MAG), the switch in response from promotion
to inhibition occurs sharply at postnatal day 3/4 (DeBel- At this stage of incomplete understanding, can we
suggest strategies for improving spinal cord regenera-lard et al., 1996). Second, inhibition of axonal regenera-
tion by MAG and myelin in culture has been shown to tion in humans? Clearly, for both ethical and practical
reasons, a conditioning peripheral nerve injury cannotbe overcome by elevated neuronal cAMP levels. Con-
versely, the growth-promoting effect of MAG or myelin be inflicted in humans to encourage growth of spinal
axons. The peripheral lesion would have to be createdon young DRG neurons is blocked by inhibitors of pro-
tein kinase A (Cai et al., 1999). Third, the repulsion of before the spinal cord injury itself, an obviously absurd
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approach. The solution, instead, is to work out what is specificity, and the ease with which radioactive or fluo-
happening at the molecular level. How can this effect rescent labels are incorporated made the a neurotoxins
be induced or mimicked in axons without a conditioning indispensable experimental tools for the study of
lesion? Can it be induced in neurons that do not have nAChRs. Their use immediately led to the identification,
a peripheral nerve branch? Why did the dorsal column purification, and localization of these receptors in mus-
axons stop growing before they reached their original cle and in the Torpedo electric organ, and made the
target? Perhaps the initial signal induced by the condi- nAChR the paradigmatic neurotransmitter receptor for
tioning lesion had subsided. If so, would a second lesion the next 20 years.
encourage them to start growing again? Answers to aBtx is an effective toxin because it inhibits the bind-
these questions could lead to a rational, molecular ap- ing of acetylcholine to the AChR, producing neuromus-
proach to encouraging CNS axons to regrow after injury. cular blockade and quick death. This efficient strategy
The next problem, of course, is then getting them to is used by a large number of poisonous snakes in the
their correct destination. Elapidae family (cobras, kraits, mambas, and tiger snakes,
among others), whose venoms collectively contain over
100 toxins with sequence homology to aBtx. All of theseMarie T. Filbin
toxins share a common structure consisting of a b sheetDepartment of Biological Sciences
core that is tightly cross-linked by four invariant disulfideHunter College of the City University of New York
bonds. Three flexible loops extend from the core to bindNew York, New York 10021
the receptor (Love and Stroud, 1986). Most of the toxins
in the family bind the nAChR, but some bind other mole-Selected Reading
cules, including muscarinic AChRs and acetylcholines-
terase.Bregman, B.S., Kunkel-Bagden, E., Schnell, L., Dai, H.N., Gao, D.,
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Neuron 22, 89±101. acetylcholine is a familiar one. Recent studies by Miwa
David, S., and Aguayo, A.J. (1981). Science 214, 931±933. et al. (1999), however, reported in this issue of Neuron,
DeBellard, M.E., Tang, S., Mukhopadhyay, G., Shen, Y., and Filbin, give this concept a new twist. They suggest that the a
M.T. (1996). Mol. Cell. Neurosci. 7, 89±101. neurotoxins not only mimic but also may be evolution-
McQuarrie, I.G., and Grafstein, B. (1973). Exp. Neurol. 29, 53±55. arily related to an endogenous ligand for the AChR, one
Neumann, S., and Woolf, C.J. (1999). Neuron 23, this issue, 83±91. that enhances rather than inhibits the action of acetyl-
Oudega, M., Varon, S., and Hagg, T. (1994). Exp. Neurol. 129, choline. This new finding not only sheds light on the
194±206. evolutionary origins of this family of toxins, but also
Richardson, P.M., and Issa, V.M.K. (1984). Nature 309, 791±793. poses the question of how the endogenous peptide
Richardson, P.M., McGuinness, U.M., and Aguayo, A.J. (1980). Na- might function physiologically to modulate the AChR.
ture 284, 264±265.
The beneficent new relative of the family of elapid
Shewan, D., Berry, M., and Cohen, J. (1995). J. Neurosci. 15, 2057±
neurotoxins is lynx1, a small (11 kDa) protein that was2062.
identified in the course of a search for developmentallySmith, D.S., and Skene, J.H.P. (1997). J. Neurosci. 17, 646±658.
regulated genes in the cerebellum. A database search
Song, H., Ming, G., Lehmann, M., McKerracher, L., Tessier-Lavigne,
using the amino acid sequence encoded by the lynx1M., and Poo, M.-M. (1998). Science 281, 1515±1518.
gene immediately revealed homology with aBtx and with
the Ly-6 family, a related group of proteins that are found
on the surface of mouse lymphocytes (Gumley et al.,
1995). The Ly-6 proteins have tertiary structures that
are similar to aBtx and are apparently attached to thea Neurotoxins and Their Relatives: surface membrane through a glycolipid anchor, where
Foes and Friends? they participate in cell±cell and cell±substrate interac-
tions. lynx1 shares with both aBtx and Ly-6 the highly
conserved motif of eight cysteines, and models show
that its predicted three-dimensional structure closelyIn 1963, C. C. Chang and C. Y. Lee initiated a new era
resembles the experimentally determined structures ofin the study of neurotransmitter receptors by showing
aBtx and CD59, a member of the Ly-6 family. Moreover,that a small protein toxin derived from the Taiwanese
the exon±intron boundaries of all three proteins are thesnake Bungarus multicinctus bound tightly and specifi-
sameÐa strong indication of a common evolutionarycally to the nicotinic acetylcholine receptor (nAChR) at
origin.the vertebrate neuromuscular junction (Chang and Lee,
What distinguishes lynx1, and makes it of unusual1963). At the time of the discovery of a-bungarotoxin
interest, is evidence suggesting that it has a functional(aBtx) and its cobratoxin relatives, the nAChR, although
relationship to AChRs in the nervous system. lynx1 isphysiologically and pharmacologically well defined, was
highly expressed in the brain, where it is associated witha molecular enigma. Even the question of whether it was
neurons in the cortex, in the hippocampus, and in thea protein was disputed. The advent of aBtx and related
cerebellum. Interestingly, each of the sites of lynx1 local-a neurotoxins completely transformed the field. Their
ization in the brain is also a site at which the a7 neuronalextremely high affinity and long off-times (making them
essentially irreversible antagonists), their extraordinary AChR is expressed. The a7 AChR, a homooligomeric
